Literature DB >> 3623837

Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation.

J S Williamson, S DiMarco, J W Streilein.   

Abstract

Inoculation of P815 tumor cells into the anterior chamber of eyes of BALB/c mice produces Anterior Chamber Associated Immune Deviation (ACAID) whereby delayed hypersensitivity responses to the minor H antigens of the tumor cells are suppressed. In our laboratory, impaired delayed hypersensitivity is obtained in the majority, but not all normal BALB/c recipients. In the minority, typcial delayed hypersensitivity responses, similar to those induced by subcutaneous immunization with tumor cells, are observed. Retrospective examination of eyes of animals that develop delayed hypersensitivity following intracameral tumor cell injection revealed a high incidence of a corneal disorder in which significant numbers of Langerhans cells are found within the corneal epithelium. BALB/c mice with corneal lesions characterized by opacity and calcium deposition, or whose corneas had become infiltrated with Langerhans cells induced to emigrate by a superficial cautery wound, received intracameral injections of P815 cells. Minimal or no significant suppression of delayed hypersensitivity was obtained, suggesting that ACAID induction had not taken place. These results suggest that the presence of Langerhans cells in the central corneal epithelium mitigates against ACAID induction.

Entities:  

Mesh:

Year:  1987        PMID: 3623837

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Immunologic privilege of the eye.

Authors:  J W Streilein
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Expression of vimentin by rabbit corneal epithelial cells during wound repair.

Authors:  N SundarRaj; J D Rizzo; S C Anderson; J P Gesiotto
Journal:  Cell Tissue Res       Date:  1992-02       Impact factor: 5.249

Review 3.  Ocular molecules and cells that regulate immune responses in situ.

Authors:  J W Streilein; S Cousins; J S Williamson
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

Review 4.  Regional differences in immune regulation: the immunogenic privilege of corneal allografts.

Authors:  J Y Niederkorn; J S Peeler
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  The chemokine receptor CX3CR1 mediates homing of MHC class II-positive cells to the normal mouse corneal epithelium.

Authors:  Holly R Chinnery; Marc J Ruitenberg; Giles W Plant; Eric Pearlman; Steffen Jung; Paul G McMenamin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

6.  Class II major histocompatibility complex (Ia) antigen-bearing dendritic cells within the iris and ciliary body of the rat eye: distribution, phenotype and relation to retinal microglia.

Authors:  P G McMenamin; I Holthouse; P G Holt
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

7.  CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.

Authors:  Molly E Skelsey; Elizabeth Mayhew; Jerry Y Niederkorn
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

8.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

9.  Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells.

Authors:  Pedram Hamrah; Lu Chen; Qiang Zhang; M Reza Dana
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 10.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.